Delivery Order SPE2DB24D2010-SPE2DB25FAARG
- Not listed
- The Defense Logistics Agency awarded a $5,852.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100. The delivery order, which represents a child contract under a larger vehicle, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This award was competitively awarded with no set-aside designation. This delivery order...
- On July 25, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,130.06 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, is issued under a non-set-aside competitive procurement and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered...
- The Defense Logistics Agency awarded a $4,497.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chew tablets (100 count) with an ultimate completion date of August 4, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency Troop Support Medical awarded a $1,813.58 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of 20 mg Quillichew ER chewable tablets. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of Department of Defense health care programs. Performance will take place in Conshohocken, Pennsylvania over a period of one day from July 20, 2023...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,088.72 to AmerisourceBergen Drug Corp for Quillichew ER Chew Tabs 40mg, a medication commonly used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $942 to Amerisourcebergen Drug Corporation to supply 4562199541 Quillichew ER 20 mg chew tablets. As the prime contractor, Amerisourcebergen will deliver 100 units of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania between September 15-18, 2023. The Defense Logistics Agency routinely issues such orders under existing pharmaceutical distribution contracts to support...
- The Defense Logistics Agency Troop Support Medical awarded a $1,010 firm fixed price delivery order against an unidentified contracting vehicle to Amerisourcebergen Drug Corporation for the supply of 100 boxes of 30mg Quillichew ER chewable tablets. To be performed at the contractor's facility in Conshohocken, Pennsylvania, the order is for delivery between June 23 and June 26, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $906 to Amerisourcebergen Drug Corporation to provide 100 units of 20mg Quillichew ER chewable tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one day period of performance from July 12 to July 13, 2023. The Defense Logistics Agency routinely issues delivery orders against various...
- This is a $2,087.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide QUILLICHEW ER 20 MG CHEW TAB 100S, a medication product. The order has a completion date of July 9, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply 4562828858 Quillichew ER 20 mg chew tabs (100s) by November 16, 2023. The $1,099.14 order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp to provide pharmaceuticals and critical care supplies in support of military treatment programs and facilities. No set-aside designation was applied....
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAARGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count units) with a ceiling value of $1,043.96. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as the primary global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The pharmaceutical procurement strategy reflects the DLA's reliance on established prime vendor relationships to maintain consistent availability of critical medical commodities across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/5/25 |